1
|
O'Hara E, Seymour J. Inducing metamorphosis in the irukandji jellyfish Carukia barnesi. Sci Rep 2022; 12:9052. [PMID: 35641559 PMCID: PMC9156746 DOI: 10.1038/s41598-022-12812-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 05/13/2022] [Indexed: 11/08/2022] Open
Abstract
Here we utilize chemical ecology as a tool to manipulate the biological system of a small, but highly venomous to humans, cubozoan jellyfish, Carukia barnesi. We trialled a range of chemical reagents including indole compounds, 9-cis-retinoic acid and lugols solution to induce metamorphosis between the polyp and medusa life stages. An optimum method was determined resulting in a 90% metamorphosis rate to healthy medusa by exposing the polyps to 1 μM of 5-methoxy-2-methylindole for 24 h. Of note is that chemical exposure time significantly impacts health and metamorphosis rates in this species. We also present a theoretical mechanism for the chemical/biological interactions occurring during metamorphosis. This is a significant methodological advancement which now enables rearing of this animal en mass in aquaria-a world first for this species-which will subsequently supply and facilitate venom research into this understudied jellyfish.
Collapse
Affiliation(s)
- E O'Hara
- Australian Institute for Tropical Health and Medicine, James Cook University, 1/14-88 McGregor Road, Smithfield, QLD, 4878, Australia.
| | - J Seymour
- Australian Institute for Tropical Health and Medicine, James Cook University, 1/14-88 McGregor Road, Smithfield, QLD, 4878, Australia
| |
Collapse
|
2
|
Xu M, Lasocki A, Bressel M, Goroncy N, Seymour J, Wheeler G, Dwyer M, Wiltshire K, Haghighi N, Mason K, Tange D, Campbell B. OC-0760 Active surveillance is safe for asymptomatic radiation-induced meningiomas in cancer survivors. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02666-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
3
|
Lasocki A, Seymour J. Central nervous system manifestations of systemic haematological malignancies and key differentials. Clin Radiol 2022; 77:328-336. [DOI: 10.1016/j.crad.2022.01.043] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Accepted: 01/11/2022] [Indexed: 02/08/2023]
|
4
|
Abrantes K, Barnett A, Soetaert M, Kyne PM, Laird A, Squire L, Seymour J, Wueringer BE, Sleeman J, Huveneers C. Potential of electric fields to reduce bycatch of highly threatened sawfishes. ENDANGER SPECIES RES 2021. [DOI: 10.3354/esr01146] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Sawfishes are among the most threatened families of marine fishes and are susceptible to incidental capture in net fisheries. Since bycatch reduction devices currently used in trawl fisheries are not effective at reducing sawfish catches, new methods to minimise sawfish bycatch are needed. Ideally, these should affect sawfish behaviour and prevent contact with the fishing gear. We tested the effects of electric fields on sawfish behaviour to assess the potential of electric pulses in mitigating sawfish bycatch. Experiments were conducted in a tank where 2 electrodes were suspended in the water column, connected to a pulse generator, and placed across the swimming path of sawfish. Two largetooth sawfish Pristis pristis were tested in control conditions, in the presence of a baseline pulse, and of 5 variations of that pulse where 1 parameter (polarity, voltage, frequency, pulse shape, pulse duration) was altered at a time. Conditional inference trees were used to identify the effects of various parameters (e.g. treatment, individual) on reaction type, reaction distance, twitching presence and duration, and inter-approach times. Sawfish reacted to electric fields, but reaction distances were small (typically <1.2 m), and no field tested consistently led to reactions conducive to escaping from moving nets. The following parameters induced the most response in both individuals: bipolar current, rectangular shaped, 5-10 Hz, ~1500 µs duration, and 100 V. We recommend further research focussing on moving nets, testing a V-shaped electric array preceding the net mouth by at least 5 m, and testing a setup similar to electrotrawling.
Collapse
Affiliation(s)
- K Abrantes
- College of Science and Engineering, James Cook University, Townsville, Qld 4811, Australia
- Biopixel Oceans Foundation, Cairns, Qld 4870, Australia
| | - A Barnett
- College of Science and Engineering, James Cook University, Townsville, Qld 4811, Australia
- Biopixel Oceans Foundation, Cairns, Qld 4870, Australia
| | - M Soetaert
- Institute for Agricultural and Fisheries Research, Animal Sciences - Fisheries, Ankerstraat 1, 8400 Oostende, Belgium
| | - PM Kyne
- Research Institute for the Environment and Livelihoods, Charles Darwin University, Darwin, NT 0815, Australia
| | - A Laird
- Northern Prawn Fishery Industry Pty Ltd, Caloundra, Qld 4551, Australia
| | - L Squire
- Cairns Marine, Cairns, Qld 4870, Australia
| | - J Seymour
- Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Qld 4870, Australia
| | - BE Wueringer
- Sharks and Rays Australia, PO Box 575, Bungalow, Cairns, Qld 4870, Australia
| | - J Sleeman
- Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Qld 4870, Australia
| | - C Huveneers
- College of Science and Engineering, Flinders University, Bedford Park, Adelaide, SA 5042, Australia
| |
Collapse
|
5
|
Campbell B, Lasocki A, Bressel M, Oon S, Goroncy N, Seymour J, Dwyer M, Wiltshire K, Mason K, Tange D, Xu M, Wheeler G. OC-0209 Radiation-induced cavernomas: investigating the role of MRI-SWI for screening and surveillance in long-term cancer survivors. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06824-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
6
|
Zwakman M, Pollock K, Bulli F, Caswell G, Červ B, van Delden JJM, Deliens L, van der Heide A, Jabbarian LJ, Koba-Čeh H, Lunder U, Miccinesi G, Arnfeldt CAM, Seymour J, Toccafondi A, Verkissen MN, Kars MC. Trained facilitators' experiences with structured advance care planning conversations in oncology: an international focus group study within the ACTION trial. BMC Cancer 2019; 19:1026. [PMID: 31672145 PMCID: PMC6822448 DOI: 10.1186/s12885-019-6170-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2018] [Accepted: 09/20/2019] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In oncology, Health Care Professionals often experience conducting Advance Care Planning (ACP) conversations as difficult and are hesitant to start them. A structured approach could help to overcome this. In the ACTION trial, a Phase III multi-center cluster-randomized clinical trial in six European countries (Belgium, Denmark, Italy, the Netherlands, Slovenia, United Kingdom), patients with advanced lung or colorectal cancer are invited to have one or two structured ACP conversations with a trained facilitator. It is unclear how trained facilitators experience conducting structured ACP conversations. This study aims to understand how facilitators experience delivering the ACTION Respecting Choices (RC) ACP conversation. METHODS A qualitative study involving focus groups with RC facilitators. Focus group interviews were recorded, transcribed, anonymized, translated into English, and thematically analysed, supported by NVivo 11. The international research team was involved in data analysis from initial coding and discussion towards final themes. RESULTS Seven focus groups were conducted, involving 28 of in total 39 trained facilitators, with different professional backgrounds from all participating countries. Alongside some cultural differences, six themes were identified. These reflect that most facilitators welcomed the opportunity to participate in the ACTION trial, seeing it as a means of learning new skills in an important area. The RC script was seen as supportive to ask questions, including those perceived as difficult to ask, but was also experienced as a barrier to a spontaneous conversation. Facilitators noticed that most patients were positive about their ACTION RC ACP conversation, which had prompted them to become aware of their wishes and to share these with others. The facilitators observed that it took patients substantial effort to have these conversations. In response, facilitators took responsibility for enabling patients to experience a conversation from which they could benefit. Facilitators emphasized the need for training, support and advanced communication skills to be able to work with the script. CONCLUSIONS Facilitators experienced benefits and challenges in conducting scripted ACP conversations. They mentioned the importance of being skilled and experienced in carrying out ACP conversations in order to be able to explore the patients' preferences while staying attuned to patients' needs. TRIAL REGISTRATION International Standard Randomised Controlled Trial Number registry 63110516 ( ISRCTN63110516 ) per 10/3/2014.
Collapse
Affiliation(s)
- M Zwakman
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
| | - K Pollock
- Faculty of Medicine and Health Sciences, School of Health Sciences, University of Nottingham, Nottingham, UK
| | - F Bulli
- Oncological network, research and prevention Institute - ISPRO, Florence, Italy
| | - G Caswell
- Faculty of Medicine and Health Sciences, School of Health Sciences, University of Nottingham, Nottingham, UK
| | - B Červ
- University Clinic for Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
| | - J J M van Delden
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
| | - L Deliens
- End-of-life Care Research Group, Vrije Universiteit Brussel, Brussels, Belgium.,Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
| | - A van der Heide
- Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
| | - L J Jabbarian
- Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
| | - H Koba-Čeh
- University Clinic for Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
| | - U Lunder
- University Clinic for Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
| | - G Miccinesi
- Oncological network, research and prevention Institute - ISPRO, Florence, Italy
| | - C A Møller Arnfeldt
- Department of Public Health, University of Copenhagen, Copenhagen, Denmark.,Department of Palliative Medicine, Bispebjerg and Frederiksberg Hospital, The Research Unit, Copenhagen, Denmark
| | - J Seymour
- University of Sheffield, Sheffield, UK
| | - A Toccafondi
- Oncological network, research and prevention Institute - ISPRO, Florence, Italy
| | - M N Verkissen
- End-of-life Care Research Group, Vrije Universiteit Brussel, Brussels, Belgium.,Ghent University, Brussels, Belgium
| | - M C Kars
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
| | | |
Collapse
|
7
|
Wu J, Bolen C, Seymour J, Hillmen P, Eichhorst B, Eldering E, Kipps T, Langerak A, Mellink C, van der Kevie-Kersemaekers A, Owen C, Chyla B, Punnoose E, Wang J, Boyer M, Humphrey K, Jiang Y, Kater A. IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.69_2629] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J. Wu
- Oncology Biomarker Development; Genentech Inc.; South San Francisco CA United States
| | - C. Bolen
- Bioinformatics and Computational Biology; Genentech Inc.; South San Francisco CA United States
| | - J.F. Seymour
- Peter MacCallum Cancer Centre; Royal Melbourne Hospital, and University of Melbourne; Melbourne Australia
| | - P. Hillmen
- Department of Haematology; St. James’ University Hospital; Leeds United Kingdom
| | - B. Eichhorst
- Department I for Internal Medicine; University of Cologne; Cologne Germany
| | - E. Eldering
- Department of Hematology, Amsterdam University Medical Centers; University of Amsterdam; Amsterdam Netherlands
| | - T.J. Kipps
- Moores Cancer Center; UC San Diego Health; San Diego CA United States
| | - A.W. Langerak
- Department of Immunology; Erasmus MC University Medical Center; Rotterdam Netherlands
| | - C. Mellink
- Genome Diagnostic Laboratory; Amsterdam University Medical Centers; Amsterdam Netherlands
| | | | - C. Owen
- Departments of Medicine and Oncology; University of Calgary; Calgary AB Canada
| | - B. Chyla
- Cancer Biomarkers; Abbvie; North Chicago IL United States
| | - E.A. Punnoose
- Oncology Biomarker Development; Genentech Inc.; South San Francisco CA United States
| | - J. Wang
- Product Development Biometrics; Genentech Inc.; South San Francisco CA United States
| | - M. Boyer
- Clinical Science; Roche Products Limited; Welwyn Garden City United Kingdom
| | - K. Humphrey
- Clinical Development Oncology; Roche Products Limited; Welwyn Garden City United Kingdom
| | - Y. Jiang
- Oncology Biomarker Development; Genentech Inc.; South San Francisco CA United States
| | - A.P. Kater
- Department of Hematology, Amsterdam University Medical Centers; University of Amsterdam; Amsterdam Netherlands
| |
Collapse
|
8
|
MacManus M, Campbell B, Wirth A, Hofman M, Hicks R, Seymour J, Burbury K. ABSCOPAL REGRESSION OF LYMPHOMA AT DISTANT SITES AFTER LOCAL RADIOTHERAPY, DETECTED BY POSITRON EMISSION TOMOGRAPHY IN SIX CASES. Hematol Oncol 2019. [DOI: 10.1002/hon.236_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- M.P. MacManus
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - B. Campbell
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - A. Wirth
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - M. Hofman
- Molecular Imaging; Peter MacCallum Cancer Centre; Melbourne Australia
| | - R. Hicks
- Molecular Imaging; Peter MacCallum Cancer Centre; Melbourne Australia
| | - J. Seymour
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - K. Burbury
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| |
Collapse
|
9
|
MacManus M, Roos D, O'Brien P, Tsang R, Wirth A, Capp A, Bressel M, Seymour J. RESULTS OF A MULTICENTER PHASE2 TRIAL OF INVOLVED FIELD RADIOTHERAPY ALONE FOR LOCALIZED NON-GASTRIC MARGINAL ZONE LYMPHOMA: TROG 05.02. Hematol Oncol 2019. [DOI: 10.1002/hon.36_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- M.P. MacManus
- Radiation Oncology; Peter MacCallum cancer Centre; Melbourne Australia
| | - D. Roos
- Radiation Oncology; Royal Adelaide Hospital; Adelaide Australia
| | - P. O'Brien
- Radiation Oncology; Genesis Care Lake Macquarie Private Hospital; Gateshead Australia
| | - R. Tsang
- Radiation Oncology; Princess Margaret Hospital; Totonto Canada
| | - A. Wirth
- Radiation Oncology; Peter MacCallum cancer Centre; Melbourne Australia
| | - A. Capp
- Radiation Oncology; Calvary Mater Hospital; Waratah Australia
| | - M. Bressel
- Radiation Oncology; Peter MacCallum cancer Centre; Melbourne Australia
| | - J. Seymour
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| |
Collapse
|
10
|
MacManus M, Fisher R, Roos D, O'Brien P, Macann A, Tsang R, Davis S, Christie D, McClure B, Joseph D, Seymour J. SYSTEMIC THERAPY AFTER RADIATION THERAPY IN STAGE I-II FOLLICULAR LYMPHOMA: FINAL RESULTS OF AN INTERNATIONAL RANDOMIZED TRIAL TROG 99.03. Hematol Oncol 2019. [DOI: 10.1002/hon.35_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- M.P. MacManus
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - R. Fisher
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - D. Roos
- Radiation Oncology; Royal Adelaide Hospital; Adelaide Australia
| | - P. O'Brien
- Radiation Oncology; GenesisCare Lake Macquarie Private Hospital; Gateshead Australia
| | - A. Macann
- Radiation Oncology; Auckland City Hospital; Auckland New Zealand
| | - R. Tsang
- Radiation Oncology; Princess Margaret Hospital; Toronto Canada
| | - S. Davis
- Radiation Oncology; Alfred Hospital; Melbourne Australia
| | - D. Christie
- Radiation Oncology; Genesis Care Premion; Southport Australia
| | - B. McClure
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - D. Joseph
- Radiation Oncology; Sir Charles Gairdner Hospital; Perth Australia
| | - J. Seymour
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| |
Collapse
|
11
|
Handunnetti S, Lew T, Lin V, Anderson M, Carney D, Wolf M, Came N, Juneja S, Westerman D, Tam C, Roberts A, Seymour J. AN UNDETECTABLE PB MRD STATUS SHOULD BE THE THERAPEUTIC GOAL WITH VENETOCLAX THERAPY IN RELAPSED/ REFRACTORY CLL. Hematol Oncol 2019. [DOI: 10.1002/hon.70_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- S.M. Handunnetti
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - T.E. Lew
- Blood Cells and Blood Cancers; Walter and Eliza Hall Institute of Medical Research; Melbourne Australia
| | - V.S. Lin
- Blood Cells and Blood Cancers; Walter and Eliza Hall Institute of Medical Research; Melbourne Australia
| | - M.A. Anderson
- Blood Cells and Blood Cancers; Walter and Eliza Hall Institute of Medical Research; Melbourne Australia
| | - D. Carney
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - M. Wolf
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - N. Came
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - S. Juneja
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - D. Westerman
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - C.S. Tam
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - A.W. Roberts
- Blood Cells and Blood Cancers; Walter and Eliza Hall Institute of Medical Research; Melbourne Australia
| | - J.F. Seymour
- Department of Hematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| |
Collapse
|
12
|
Tam C, Opat S, Zhu J, Cull G, Gottlieb D, Li J, Marlton P, Qiu L, Roberts A, Seymour J, Simpson D, Song Y, Yang H, Du C, Feng S, Ji M, Lin L, Novotny W, Wang A, Trotman J. PS1159 POOLED ANALYSIS OF SAFETY DATA FROM MONOTHERAPY STUDIES OF THE BRUTON TYROSINE KINASE (BTK) INHIBITOR, ZANUBRUTINIB (BGB-3111), IN B-CELL MALIGNANCIES. Hemasphere 2019. [DOI: 10.1097/01.hs9.0000562920.26603.5b] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
13
|
Çağlayan Ç, Dixon J, Salles G, Wall A, Schmitz N, Cunningham D, Poeschel V, Seymour J, Jaeger U, Habermann T, Merli F, Haioun C, Tilly H, Ghesiquieres H, Ziepert M, Flament J, Shi Q, Flowers C. THE CLINICAL COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) OVER TIME: A MULTISTATE SURVIVAL ANALYSIS USING META-DATA FROM 13 FIRST-LINE RANDOMIZED TRIALS. Hematol Oncol 2019. [DOI: 10.1002/hon.56_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Ç. Çağlayan
- Industrial and Systems Engineering; Georgia Institute of Technology; Atlanta GA United States
| | - J.G. Dixon
- Department of Health Sciences Research; Mayo Clinic; Rochester MN United States
| | - G. Salles
- Hematology; Hospices Civils de Lyon; Lyon France
| | - A. Wall
- Department of Health Sciences Research; Mayo Clinic; Rochester MN United States
| | - N. Schmitz
- Hematology and Oncology; University Hospital Muenster; Muenster Germany
| | - D. Cunningham
- Department of Medicine; The Royal Marsden Hospital; Sutton United Kingdom
| | - V. Poeschel
- Medical School; Saarland University; Homburg Germany
| | - J. Seymour
- Clinical Research; Integrated Haematology, Peter MacCallum Cancer Centre; Melbourne Australia
| | - U. Jaeger
- Department of Medicine I; Medical University of Vienna; Vienna Austria
| | - T. Habermann
- Cancer Center; Hematology, Mayo Clinic; Rochester MN United States
| | - F. Merli
- Hematology; AUSL-IRCCS; Reggio Emilia Italy
| | - C. Haioun
- Unite Hemopathies Lymphoides; Hopital Henri Mondor; Creteil France
| | - H. Tilly
- Hématologie; Centre Henri-Becquerel; Rouen France
| | - H. Ghesiquieres
- Service d'Hématologie; Centre Hospitalier Lyon-Sud, Pierre Bénite CEDEX; France
| | - M. Ziepert
- Institut für Medizinische Informatik; Statistik und Epidemiologie, Universität Leipzig; Leipzig Germany
| | - J. Flament
- Medicine and Biology; Celgene Corporation; Boudry Switzerland
| | - Q. Shi
- Department of Health Sciences Research; Mayo Clinic; Rochester MN United States
| | - C. Flowers
- Winship Cancer Institute; Emory University; Atlanta GA United States
| |
Collapse
|
14
|
Lewis K, Dowling M, Bavishi K, Øvlisen A, Hamad N, Choi P, Grigg A, P'Ng S, Filshie R, Ritchie D, Bilmon I, Prince H, Wolf M, Hertzberg M, Chuah H, El-Galaly T, Tam C, Seymour J, Cheah C. CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL LYMPHOMAS. Hematol Oncol 2019. [DOI: 10.1002/hon.221_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- K.L. Lewis
- Department of Haematology; Sir Charles Gairdner Hospital; Perth Australia
| | - M. Dowling
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - K. Bavishi
- Department of Haematology; Cairns Hospital; Cairns Australia
| | - A.K. Øvlisen
- Department of Haematology; Aalborg University Hospital; Aalborg Denmark
| | - N. Hamad
- Department of Haematology; St Vincent's Health Australia; Sydney Australia
| | - P. Choi
- Department of Haematology; The Canberra Hospital; Canberra Australia
| | - A. Grigg
- Department of Haematology; Austin Hospital; Melbourne Australia
| | - S. P'Ng
- Department of Haematology; Fiona Stanley Hospital; Perth Australia
| | - R. Filshie
- Department of Haematology; St Vincent's Hospital; Melbourne Australia
| | - D.S. Ritchie
- Department of Clinical Haematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - I. Bilmon
- Department of Haematology; Westmead Hospital; Sydney Australia
| | - H.M. Prince
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - M. Wolf
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - M. Hertzberg
- Department of Haematology; Prince of Wales Hospital and UNSW; Randwick Australia
| | - H. Chuah
- Department of Haematology; Rockingham General Hospital; Perth Australia
| | - T.C. El-Galaly
- Department of Haematology; Aalborg University Hospital; Aalborg Denmark
| | - C.S. Tam
- Department of Haematology; Peter MacCallum Cancer Centre, St Vincent's Hospital and University of Melbourne; Melbourne Australia
| | - J.F. Seymour
- Department of Clinical Haematology; Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Melbourne Australia
| | - C.Y. Cheah
- Department of Haematology; Sir Charles Gairdner Hospital; Perth Australia
| |
Collapse
|
15
|
Fessler L, Wright K, Pace G, Andrews S, Davis M, Raffensperger K, Seymour J, Lagergren M, West N, Merlo C, Shah P. Assessment of Pre-Transplant Perceptions during Transition to Lung Transplant. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
16
|
Little M, Pereira P, Mulcahy R, Cullen P, Carrette T, Seymour J. Severe Cardiac Failure Associated with Presumed Jellyfish Sting. Irukandji Syndrome? Anaesth Intensive Care 2019; 31:642-7. [PMID: 14719425 DOI: 10.1177/0310057x0303100605] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
We present a retrospective review of twelve cases of Irukandji syndrome associated with pulmonary oedema. This is a life-threatening envenoming due to a presumed jellyfish sting throughout Northern Australia, although only one case occurred outside North Queensland. Patients presented with significant and ongoing pain, tachycardia and hypertension. Half the patients became hypotensive requiring inotropic support. Cardiac echocardiography revealed significant cardiac dysfunction. Six patients required ventilatory support. There was no death reported due to pulmonary oedema, but one patient died of intracerebral haemorrhage. We believe patients may develop a toxin associated cardiomyopathy, and jellyfish other than Carukia barnesi may be responsible. As there is confusion with nomenclature, Carukia barnesi should be known as the Barnes jellyfish, and the diagnosis of cardiotoxic marine envenoming is suggested for any patient who has been stung by a jellyfish, develops no or minimal skin markings, and develops cardiogenic pulmonary oedema associated with Irukandji syndrome.
Collapse
Affiliation(s)
- M Little
- Department of Emergency Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia
| | | | | | | | | | | |
Collapse
|
17
|
Seymour J, Snow J, Thompson TA, Garnsey C, Kohn J, Grossman D. Patient-reported acceptability of receiving medication for abortion via telemedicine at Planned Parenthood health centers in seven states. Contraception 2018. [DOI: 10.1016/j.contraception.2018.07.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Zwakman M, Jabbarian LJ, van Delden JJM, van der Heide A, Korfage IJ, Pollock K, Rietjens JAC, Seymour J, Kars MC. Advance care planning: A systematic review about experiences of patients with a life-threatening or life-limiting illness. Palliat Med 2018; 32:1305-1321. [PMID: 29956558 PMCID: PMC6088519 DOI: 10.1177/0269216318784474] [Citation(s) in RCA: 104] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND Advance care planning is seen as an important strategy to improve end-of-life communication and the quality of life of patients and their relatives. However, the frequency of advance care planning conversations in practice remains low. In-depth understanding of patients' experiences with advance care planning might provide clues to optimise its value to patients and improve implementation. AIM To synthesise and describe the research findings on the experiences with advance care planning of patients with a life-threatening or life-limiting illness. DESIGN A systematic literature review, using an iterative search strategy. A thematic synthesis was conducted and was supported by NVivo 11. DATA SOURCES The search was performed in MEDLINE, Embase, PsycINFO and CINAHL on 7 November 2016. RESULTS Of the 3555 articles found, 20 were included. We identified three themes in patients' experiences with advance care planning. 'Ambivalence' refers to patients simultaneously experiencing benefits from advance care planning as well as unpleasant feelings. 'Readiness' for advance care planning is a necessary prerequisite for taking up its benefits but can also be promoted by the process of advance care planning itself. 'Openness' refers to patients' need to feel comfortable in being open about their preferences for future care towards relevant others. CONCLUSION Although participation in advance care planning can be accompanied by unpleasant feelings, many patients reported benefits of advance care planning as well. This suggests a need for advance care planning to be personalised in a form which is both feasible and relevant at moments suitable for the individual patient.
Collapse
Affiliation(s)
- M Zwakman
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
- Marieke Zwakman, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Stratenum 6.131, PO Box 85500, 3508 GA Utrecht, The Netherlands.
| | - LJ Jabbarian
- Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
| | - JJM van Delden
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - A van der Heide
- Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
| | - IJ Korfage
- Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
| | - K Pollock
- School of Health Sciences, University of Nottingham, Nottingham, UK
| | - JAC Rietjens
- Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
| | - J Seymour
- School of Nursing and Midwifery, University of Sheffield, Sheffield, UK
| | - MC Kars
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
19
|
Trotman J, Opat S, Marlton P, Gottlieb D, Simpson D, Cull G, Ritchie D, Verner E, Ratnasingam S, Anderson M, Wood P, Wang L, Xue L, Hedrick E, Huang J, Hilger J, Seymour J, Roberts A, Tam C. BRUTON'S TYROSINE KINASE (BTK) INHIBITOR BGB-3111 DEMONSTRATES HIGH VERY GOOD PARTIAL RESPONSE (VGPR) RATE IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA (WM). Hematol Oncol 2017. [DOI: 10.1002/hon.2437_58] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J. Trotman
- Department of Haematology; Concord Repatriation General Hospital; Concord Australia
| | - S. Opat
- Clinical Haematology; Monash Health; Clayton Australia
| | - P. Marlton
- Leukaemia and Lymphoma Services, Princess Alexandra Hospital; University of Queensland School of Medicine; Brisbane Australia
| | - D. Gottlieb
- Haematology Department; Westmead Hospital; Westmead Australia
| | - D. Simpson
- Department of Haematology; North Shore Hospital; Aukland New Zealand
| | - G. Cull
- Department of Haematology; Sir Charles Gairdner Hospital; Perth Australia
| | - D. Ritchie
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - E. Verner
- Department of Haematology; Concord Repatriation General Hospital; Concord Australia
| | | | - M. Anderson
- Cancer and Haematology; University of Melbourne; Melbourne Australia
| | - P. Wood
- Leukaemia and Lymphoma Services, Princess Alexandra Hospital; University of Queensland School of Medicine; Brisbane Australia
| | - L. Wang
- Research and Development Center; BeiGene, Beijing and Emeryville; CA, US China
| | - L. Xue
- Research and Development Center; BeiGene, Beijing and Emeryville; CA, US China
| | - E. Hedrick
- Research and Development Center; BeiGene, Beijing and Emeryville; CA, US China
| | - J. Huang
- Research and Development Center; BeiGene, Beijing and Emeryville; CA, US China
| | - J. Hilger
- Research and Development Center; BeiGene, Beijing and Emeryville; CA, US China
| | - J.F. Seymour
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - A.W. Roberts
- Cancer and Haematology; University of Melbourne; Melbourne Australia
| | - C.S. Tam
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| |
Collapse
|
20
|
Macmanus M, Fisher R, Roos D, O'Brien P, Macann A, Tsang R, Davis S, Christie D, McClure B, Joseph D, Seymour J. CVP OR R-CVP GIVEN AFTER INVOLVED-FIELD RADIOTHERAPY IMPROVES PROGRESSION FREE SURVIVAL IN STAGE I-II FOLLICULAR LYMPHOMA: RESULTS OF AN INTERNATIONAL RANDOMIZED TRIAL. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_11] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- M.P. Macmanus
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - R. Fisher
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - D. Roos
- Radiation Oncology; Royal Adelaide Hospital; Adelaide Australia
| | - P. O'Brien
- Radiation Oncology; Genesis Healthcare; Gateshead Australia
| | - A. Macann
- Radiation Oncology; Auckland City Hospital; Auckland New Zealand
| | - R. Tsang
- Radiation Oncology; Princess Margaret Hospital; Toronto Canada
| | - S. Davis
- Radiation Oncology; Alfred Hospital; Melbourne Australia
| | - D. Christie
- Radiation Oncology; Genesis CancerCare Southport; Southport Australia
| | - B. McClure
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - D. Joseph
- Radiation Oncology; Sir Charles Gairdner Hospital; Perth Australia
| | - J.F. Seymour
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| |
Collapse
|
21
|
Seymour J, Opat S, Cull G, Trotman J, Gottlieb D, Simpson D, Marlton P, Anderson M, Ku M, Ritchie D, Ratnasingam S, Augustson B, Kim W, Wang L, Xue L, Hilger J, Huang J, Hedrick E, Roberts A, Tam C. HIGH OVERALL RESPONSE RATE WITH THE BTK INHIBITOR BGB-3111 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: AN UPDATE ON SAFETY AND ACTIVITY. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_97] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- J.F. Seymour
- Department of Haematology; Peter MacCallum Cancer Centre; East Melbourne Australia
| | - S. Opat
- Clinical Haematology; Monash Health; Clayton Australia
| | - G. Cull
- Department of Haematology; Sir Charles Gairdner Hospital; Perth Australia
| | - J. Trotman
- Department of Haematology; Concord Hospital; Concord Australia
| | - D. Gottlieb
- Haematology Department; Westmead Hospital; Westmead Australia
| | - D. Simpson
- Aukland Haematology; North Shore Hospital; Aukland New Zealand
| | - P. Marlton
- University of Queensland School of Medicine; Princess Alexandra Hospital; Brisbane Australia
| | - M. Anderson
- Department of Clinical Haematology & BMT, The Royal Melbourne Hospital; University of Melbourne; Parkville Australia
| | - M. Ku
- Clinical Haematology, Austin Health; Heidelberg Australia
| | - D.S. Ritchie
- Department of Haematology; Peter MacCallum Cancer Centre; East Melbourne Australia
| | | | - B. Augustson
- Department of Haematology; Sir Charles Gairdner Hospital; Perth Australia
| | - W. Kim
- Division of Hematology-Oncology; Samsung Medical Center; Seoul Korea, Republic of
| | - L. Wang
- Research and Development Center, BeiGene, Beijing and Emeryville; CA, US China
| | - L. Xue
- Research and Development Center, BeiGene, Beijing and Emeryville; CA, US China
| | - J. Hilger
- Research and Development Center, BeiGene, Beijing and Emeryville; CA, US China
| | - J. Huang
- Research and Development Center, BeiGene, Beijing and Emeryville; CA, US China
| | - E. Hedrick
- Research and Development Center, BeiGene, Beijing and Emeryville; CA, US China
| | - A.W. Roberts
- Department of Clinical Haematology & BMT, The Royal Melbourne Hospital; University of Melbourne; Parkville Australia
| | - C.S. Tam
- Department of Haematology; Peter MacCallum Cancer Centre; East Melbourne Australia
| |
Collapse
|
22
|
Anderson M, Lew T, Seymour J, Roberts A, Tam C. OUTCOMES WITH BRUTON TYROSINE KINASE INHIBITION IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA AFTER PROGRESSION ON VENETOCLAX. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_99] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- M. Anderson
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| | - T.E. Lew
- Cancer and Haematology; Walter and Eliza Hall Institute; Parkville Australia
| | - J.F. Seymour
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| | - A.W. Roberts
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| | - C. Tam
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| |
Collapse
|
23
|
|
24
|
Tang L, Dolnik A, MacBeth K, Dombret H, Seymour J, Minden M, Stone R, Beach C, Döhner H, Bullinger L. Impact of Gene Mutations on Survival with Azacitidine or Conventional Care Regimens (CCR) in Older Patients with Acute Myeloid Leukemia. Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30223-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Seymour J, Buckstein R, Santini V, Döhner H, Stone R, Minden M, Kuo C, Ben-Yehuda D, Bargay J, Songer S, Weaver J, Beach C, Dombret H. Azacitidine Versus Conventional Care Regimens (CCR) in Elderly Patients (≥75 Years) with Acute Myeloid Leukemia (AML) in the AZA-AML-001 Study. Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30221-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
26
|
Schuh A, Döhner H, Seymour J, Turlure P, Junghanss C, MacWhannell A, Tu N, Songer S, Beach C, Dombret H. Stable Disease with Hematologic Improvement is Clinically Meaningful for Older Patients with Acute Myeloid Leukemia (AML) Treated with Azacitidine. Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30222-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
27
|
Kampasi K, Seymour J, Stark E, Buzsaki G, Wise KD, Yoon E. Efficient assembly of multi-color fiberless optoelectrodes with on-board light sources for neural stimulation and recording. Annu Int Conf IEEE Eng Med Biol Soc 2017; 2016:4479-4482. [PMID: 28269273 DOI: 10.1109/embc.2016.7591722] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Fiberless optoelectrodes are an emerging tool to enable brain circuit mapping by providing precise optical modulation and electrical monitoring of many neurons. While optoelectrodes having an on-board light source offer compact and optically efficient device solutions, many of them fail to provide robust thermal and electrical design to fully exploit the recording capabilities of the device. In this work, we present a novel fiberless multicolor optoelectrode solution, which meets the optical and thermal design requirements of an in vivo neural optoelectrode and offers potential for low-noise neural recording. The total optical loss measured for 405 nm and 635 nm wavelengths through the waveguide is 11.7±1.1 dB and 9.9±0.7 dB, corresponding to respective irradiances of 1928 mW/mm2 and 2905 mW/mm2 at the waveguide tip from 6 mW laser diode chips. The efficient thermal packaging enables continuous device operation for up to 190 seconds at 10% duty cycle. We validated the fully packaged device in the intact brain of anesthetized mice co-expressing Channelrhodopsin-2 and Archaerhodopsin in the hippocampal CA1 region and achieved activation and silencing of the same neurons. We discuss improvements made to reduce the stimulation artifact induced by applying currents to the laser diode chips.
Collapse
|
28
|
Vitolo U, Seymour J, Martelli M, Illerhaus G, Illidge T, Zucca E, Campo E, Ladetto M. Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27:v91-v102. [DOI: 10.1093/annonc/mdw175] [Citation(s) in RCA: 73] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
|
29
|
MacManus M, Wirth A, Campbell B, Khor R, Ryan G, Seymour J. High Rate of Progression Free Survival and Exceptional Overall Survival in FDG-PET-Staged Patients With Stage III Follicular Lymphoma Treated With Comprehensive Lymphatic Irradiation. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Ng S, Khor R, Bressel M, MacManus M, Seymour J, Hicks R, Wirth A. Impact of 18-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Stage on Outcomes Among Patients With Early-Stage Follicular Lymphoma. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
31
|
Hillen M, Seymour J, Yeo J, Griffiths G, Howd A. A prospective study to establish whether the malnutrition universal screening tool (MUST) score can independently predict outcomes of patients undergoing reconstructive surgery or amputation for critical limb ischaemia (CLI). Int J Surg 2015. [DOI: 10.1016/j.ijsu.2015.07.627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
32
|
Musa I, Seymour J, Wada T, Narayanasamy M, Conroy S. 50 * A SURVEY OF OLDER PEOPLES' ATTITUDES TOWARDS ADVANCE CARE PLANNING. Age Ageing 2015. [DOI: 10.1093/ageing/afv033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
33
|
Garcia-Manero G, Silverman L, Komrokji R, Mufti G, Seymour J, Tsai K, Reiser D, Skikne B, Beach C, Fenaux P. 57 A PHASE 2 MULTICENTER STUDY OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WHO FAIL TO ACHIEVE RESPONSE WITH INJECTABLE AZACITIDINE OR DECITABINE. Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30058-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
34
|
Döhner H, Seymour J, Butrym A, Wierzbowska A, Selleslag D, Jang J, Cavenagh J, Kumar R, Schuh A, Candoni A, Récher C, Sandhu I, del Castillo TB, Al-Ali H, Martinelli G, Falantes J, Nopenney R, Stone R, Minden M, McIntyre H, Songer S, Lucy L, Beach C, Dombret H. 96 OVERALL SURVIVAL IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML WITH >30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETICS TREATED WITH AZACITIDINE: SUBANALYSIS OF THE AZA-AML-001 STUDY. Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30097-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Ewing G, Ngwenya N, Farquhar M, Benson J, Gilligan D, Seymour J, Bailey S. HOW DO PATIENTS SHARE NEWS OF A CANCER DIAGNOSIS WITH FAMILY/FRIENDS; NEW UNDERSTANDINGS OF THE PROCESS AFTER BAD NEWS HAS BEEN BROKEN. BMJ Support Palliat Care 2015. [DOI: 10.1136/bmjspcare-2014-000838.32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Seymour J, Nedelcu D. P154 The Impact Of A Discharge Care Bundle On The 30-day Readmission Rate Following Hospitalisation For Acute Copd Exacerbation. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.283] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
37
|
Seymour J, Horstmann-Dehn L, Wooller MJ. Proportion of higher trophic-level prey in the diet of Pacific walruses (Odobenus rosmarus divergens). Polar Biol 2014. [DOI: 10.1007/s00300-014-1492-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Wilson E, Morbey H, Brown J, Payne S, Seale C, Seymour J. HOW DO COMMUNITY NURSES DECIDE WHEN TO USE ANTICIPATORY PRESCRIPTIONS IN END OF LIFE CARE AND WHAT DO THEY WORRY ABOUT? FINDINGS FROM A QUALITATIVE STUDY. BMJ Support Palliat Care 2014. [DOI: 10.1136/bmjspcare-2014-000653.3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
39
|
Hardy B, Caswell G, Ewing G, Grande G, Kennedy S, Tabreham J, Seymour J. DEVELOPING TRAINING FOR SUPPORTERS OF LAY-CARERS INVOLVED WITH HOME BASED END OF LIFE CARE: A PARTICIPATORY APPROACH. BMJ Support Palliat Care 2014. [DOI: 10.1136/bmjspcare-2014-000653.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
40
|
Ewing G, Ngwenya N, Farquhar M, Gilligan D, Bailey S, Benson J, Seymour J. SHARING BAD NEWS: DEVELOPMENT OF AN INTERVENTION TO SUPPORT PATIENTS WITH LUNG CANCER SHARE NEWS OF THEIR CANCER DIAGNOSIS WITH FAMILY MEMBERS AND FRIENDS. BMJ Support Palliat Care 2014. [DOI: 10.1136/bmjspcare-2014-000653.29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
41
|
Seymour J, Horstmann-Dehn L, Wooller MJ. Inter-annual variability in the proportional contribution of higher trophic levels to the diet of Pacific walruses. Polar Biol 2014. [DOI: 10.1007/s00300-014-1460-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Seymour J, Horstmann-Dehn L, Rosa C, Lopez J. Occurrence and genotypic analysis of Trichinella species in Alaska marine-associated mammals of the Bering and Chukchi seas. Vet Parasitol 2014; 200:153-64. [DOI: 10.1016/j.vetpar.2013.11.015] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2013] [Revised: 11/13/2013] [Accepted: 11/18/2013] [Indexed: 10/26/2022]
|
43
|
Ngwenya N, Farquhar M, Benson J, Gilligan D, Bailey S, Seymour J, Ewing G. 102 Sharing Bad News: Understanding the communication processes of a lung cancer diagnosis. Lung Cancer 2014. [DOI: 10.1016/s0169-5002(14)70102-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
44
|
Gott M, Ingleton C, Gardiner C, Richards N, Cobb M, Ryan T, Noble B, Bennett M, Seymour J, Ward S, Parker C. Transitions to palliative care for older people in acute hospitals: a mixed-methods study. Health Services and Delivery Research 2013. [DOI: 10.3310/hsdr01110] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BackgroundImproving the provision of palliative and end-of-life care is a priority for the NHS. Ensuring an appropriately managed ‘transition’ to a palliative approach for care when patients are likely to be entering the last year of life is central to current policy. Acute hospitals represent a significant site of palliative care delivery and specific guidance has been published regarding the management of palliative care transitions within this setting.Aims(1) to explore how transitions to a palliative care approach are managed and experienced in acute hospitals and to identify best practice from the perspective of clinicians and service users; (2) to examine the extent of potentially avoidable hospital admissions amongst hospital inpatients with palliative care needs.DesignA mixed-methods design was adopted in two hospitals in England, serving diverse patient populations. Methods included (1) two systematic reviews; (2) focus groups and interviews with 58 health-care professionals to explore barriers to, and facilitators of, palliative care transitions in hospital; (3) a hospital inpatient survey examining palliative care needs and aspects of management including a self-/proxy-completed questionnaire, a survey of medical and nursing staff and a case note review; (4) in-depth interviews with 15 patients with palliative care needs; (5) a retrospective case note review of all inpatients present in the hospital at the time of the survey who had died within the subsequent 12 months; and (6) focus groups with 83 key decision-makers to explore the implications of the findings for service delivery and policy.ResultsOf the 514 patients in the inpatient survey sample, just over one-third (n = 185, 36.0%) met one or more of the Gold Standards Framework (GSF) prognostic indicator criteria for palliative care needs. The most common GSF prognostic indicator was frailty, with almost one-third of patients (27%) meeting this criteria. Agreement between medical and nursing staff and the GSF with respect to identifying patients with palliative care needs was poor. In focus groups, health professionals reported difficulties in recognising that a patient had entered the last 12 months of life. In-depth interviews with patients found that many of those interviewed were unaware of their prognosis and showed little insight into what they could expect from the trajectory of their disease. The retrospective case note review found that 35 (7.2%) admissions were potentially avoidable. The potential annual cost saving across both hospitals of preventing these admissions was approximately £5.3M. However, a 2- or 3-day reduction in length of stay for these admissions would result in an annual cost saving of £21.6M or £32.4M respectively.ConclusionsPatients with palliative care needs represent a significant proportion of the hospital inpatient population. There is a significant gap between NHS policy regarding palliative and end-of-life care management in acute hospitals in England and current practice.FundingThe National Institute for Health Research Health Services and Delivery Research programme.
Collapse
Affiliation(s)
- M Gott
- School of Nursing, University of Auckland, Auckland, New Zealand
| | - C Ingleton
- School of Nursing and Midwifery, University of Sheffield, Sheffield, UK
| | - C Gardiner
- School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK
| | - N Richards
- Department of Sociological Studies, University of Sheffield, Sheffield, UK
| | - M Cobb
- Directorate of Professional Services, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
| | - T Ryan
- School of Nursing and Midwifery, University of Sheffield, Sheffield, UK
| | - B Noble
- Department of Oncology, University of Sheffield, Sheffield, UK
| | - M Bennett
- School of Medicine, University of Leeds, Leeds, UK
| | - J Seymour
- School of Nursing, Midwifery and Physiotherapy, University of Nottingham, Nottingham, UK
| | - S Ward
- School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK
| | - C Parker
- No affiliation (retired) – medical statistician
| |
Collapse
|
45
|
Cheah C, George A, Giné E, Chiappella A, Kluin-Nelemans H, Jurczak W, Krawczyk K, Mocikova H, Klener P, Salek D, Walewski J, Szymczyk M, Smolej L, Auer R, Ritchie D, Arcaini L, Williams M, Dreyling M, Seymour J. Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol 2013; 24:2119-23. [DOI: 10.1093/annonc/mdt139] [Citation(s) in RCA: 82] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
McDermott E, Bingley AF, Thomas C, Payne S, Seymour J, Clark D. Viewing patient need through professional writings: a systematic 'ethnographic' review of palliative care professionals' experiences of caring for people with cancer at the end of life. Progress in Palliative Care 2013. [DOI: 10.1179/096992606x93362] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
47
|
Wirth A, Gospodarowicz M, Aleman B, Bressel M, Ng A, Chao M, Hoppe R, Thieblemont C, Tsang R, Moser L, Specht L, Szpytma T, Lennard A, Seymour J, Zucca E. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study. Ann Oncol 2013; 24:1344-51. [DOI: 10.1093/annonc/mds623] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
|
48
|
Dickinson M, Herbert K, Sardjono C, Le T, Link E, Zannino D, Ruell S, Seymour J, Kenealy M, Prince H. P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML. Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70323-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Kenealy M, Seymour J, Benson W, Stevenson W, Eek R, Zantomio D, Cunningham I, Hiwase D, Cowan L, Zannino D. P-272 The combination of azacitidine and lenalidomide is deliverable without unexpected toxicity; interim safety results of the ALLG MDS4 randomised trial. Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70319-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
50
|
Hanratty B, Lowson E, Grande G, Addington-Hall J, Seymour J, Payne S. A STUDY OF SOCIOECONOMIC DISADVANTAGE AND END-OF-LIFE HOSPITAL ADMISSIONS FOR OLDER PEOPLE WITH HEART FAILURE AND LUNG CANCER IN ENGLAND. BMJ Support Palliat Care 2013. [DOI: 10.1136/bmjspcare-2013-000453b.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|